GlassScriptPhysician profile
Jeffrey J Murray
NPI 1982019832
$3,886.90
in general payments reported to CMS, 2019-2025
30 companies · $1,162 in 2025
The $1,162 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $210 · 2021: $499 · 2022: $99.33 · 2023: $835 · 2024: $913 · 2025: $1,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,872 · Education: $37.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,872.07 |
| Education | $37.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $604.10 | 2023-2025 | Watchman Access System, Watchman Flx |
| Pfizer INC. | $593.98 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $445.68 | 2020-2025 | |
| Abbott Laboratories | $363.70 | 2020-2025 | Aveir |
| Amgen INC. | $203.73 | 2020-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $167.37 | 2021-2025 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $166.98 | 2021-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $135.78 | 2020-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $122.16 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $110.43 | 2023-2025 | Verquvo |
| Medicure Pharma INC. | $104.73 | 2023 | Zypitamag |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.32 | 2024-2025 | Jardiance |
| Siemens Medical Solutions USA, INC. | $90.87 | 2025 | Acuson Origin Diagnostic Ultrasound System |
| Astrazeneca Pharmaceuticals LP | $80.56 | 2020-2025 | Wainua |
| Heartflow, INC. | $77.21 | 2024-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $76.25 | 2020-2025 | Definity |
| Janssen Pharmaceuticals, INC | $69.82 | 2020-2024 | Xarelto |
| Baxter Healthcare | $50.31 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $44.35 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $40.12 | 2021 | |
| Scpharmaceuticals INC. | $40.08 | 2024-2025 | |
| Chiesi USA, INC. | $36.04 | 2019-2024 | Juxtapid |
| Lexicon Pharmaceuticals, INC. | $26.95 | 2024 | |
| W. L. Gore & Associates, INC. | $23.20 | 2020 | |
| Ardelyx, INC. | $22.11 | 2024 | Ibsrela |
| Novo Nordisk INC | $19.40 | 2025 | Rybelsus, Ozempic |
| Vital Connect, INC | $18.95 | 2025 | Vitalpatch Rtm |
| Kiniksa Pharmaceuticals, LTD. | $18.75 | 2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $18.25 | 2023 | |
| Medtronic, INC. | $16.72 | 2023 | Linq II |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.